Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael L Cher

Showing results (31-40 of 112) with videos related to

Pageof 12
Sort By:
Neoplasia (New York, N.Y.)|April 1, 2005
Bone microenvironment modulates expression and activity of cathepsin B in prostate cancerIzabela Podgorski, Bruce E Linebaugh, Mansoureh Sameni, et al.
Urology|January 26, 2022
Practice-Level Variation in the Decision to Biopsy Prostate Imaging-Reporting and Data System 3 Lesions in Favorable-Risk Prostate Cancer PatientsDerek Versalle, Ji Qi, Sabrina L Noyes, et al.
Molecular Cancer|August 2, 2013
PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signalingM Katie Conley-LaComb, Allen Saliganan, Pridvi Kandagatla, et al.
Clinical & Experimental Metastasis|June 1, 2004
Angiogenic and antiangiogenic balance regulates concomitant antitumoral resistanceO Graciela Scharovsky, M Mercedes Binda, Viviana R Rozados, et al.
Cancer|January 28, 2003
Third North American Symposium on Skeletal Complications of Malignancy: summary of the scientific sessionsSuresh Mohla, Katherine N Weilbacher, Michael L Cher, et al.
Cancer Research|June 17, 2010
Shedding of RANKL by tumor-associated MT1-MMP activates Src-dependent prostate cancer cell migrationAaron L Sabbota, Hyeong-Reh Choi Kim, Xiaoning Zhe, et al.
The Journal of Urology|December 3, 2014
MUSIC: patterns of care in the radiographic staging of men with newly diagnosed low risk prostate cancerIshai Ross, Paul Womble, Jun Ye, et al.
European Urology Focus|August 13, 2022
Trials in the Key of G: Building Level 1 Evidence on the Real-world Effectiveness of Prostate BiomarkersLinda A Okoth, Anna C Harris, Udit Singhal, et al.
Clinical Prostate Cancer|March 26, 2004
Ten-year survival after radical prostatectomy: specimen Gleason score is the predictor in organ-confined prostate cancerFernando J Bianco, David P Wood, Michael L Cher, et al.
Cancer|January 22, 2024
Determinants of active surveillance uptake in a diverse population-based cohort of men with low-risk prostate cancer: The Treatment Options in Prostate Cancer Study (TOPCS)Jinping Xu, Cathryn H Bock, James Janisse, et al.
Pageof 12

Showing results (31-40 of 112) with videos related to

Sort By:
Pageof 12
Neoplasia (New York, N.Y.)|April 1, 2005
Bone microenvironment modulates expression and activity of cathepsin B in prostate cancerIzabela Podgorski, Bruce E Linebaugh, Mansoureh Sameni, et al.
Urology|January 26, 2022
Practice-Level Variation in the Decision to Biopsy Prostate Imaging-Reporting and Data System 3 Lesions in Favorable-Risk Prostate Cancer PatientsDerek Versalle, Ji Qi, Sabrina L Noyes, et al.
Molecular Cancer|August 2, 2013
PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signalingM Katie Conley-LaComb, Allen Saliganan, Pridvi Kandagatla, et al.
Clinical & Experimental Metastasis|June 1, 2004
Angiogenic and antiangiogenic balance regulates concomitant antitumoral resistanceO Graciela Scharovsky, M Mercedes Binda, Viviana R Rozados, et al.
Cancer|January 28, 2003
Third North American Symposium on Skeletal Complications of Malignancy: summary of the scientific sessionsSuresh Mohla, Katherine N Weilbacher, Michael L Cher, et al.
Cancer Research|June 17, 2010
Shedding of RANKL by tumor-associated MT1-MMP activates Src-dependent prostate cancer cell migrationAaron L Sabbota, Hyeong-Reh Choi Kim, Xiaoning Zhe, et al.
The Journal of Urology|December 3, 2014
MUSIC: patterns of care in the radiographic staging of men with newly diagnosed low risk prostate cancerIshai Ross, Paul Womble, Jun Ye, et al.
European Urology Focus|August 13, 2022
Trials in the Key of G: Building Level 1 Evidence on the Real-world Effectiveness of Prostate BiomarkersLinda A Okoth, Anna C Harris, Udit Singhal, et al.
Clinical Prostate Cancer|March 26, 2004
Ten-year survival after radical prostatectomy: specimen Gleason score is the predictor in organ-confined prostate cancerFernando J Bianco, David P Wood, Michael L Cher, et al.
Cancer|January 22, 2024
Determinants of active surveillance uptake in a diverse population-based cohort of men with low-risk prostate cancer: The Treatment Options in Prostate Cancer Study (TOPCS)Jinping Xu, Cathryn H Bock, James Janisse, et al.
Pageof 12